Policomponent Phytotherapy in Treatment in Diseases of Рrostatae
##plugins.themes.bootstrap3.article.main##
Abstract
##plugins.themes.bootstrap3.article.details##
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright and grant the journal the first publication of original scientific articles under the Creative Commons Attribution 4.0 International License, which allows others to distribute work with acknowledgment of authorship and first publication in this journal.
References
Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol. 2015 Oct;22(5 Suppl 1):1-6.
Sciarra A., Di Silverio F., Salciccia S. et al. 2007 Inflammation and Chronic Prostatic Diseases: Evidence for a Link? Eur. Urol.: 52. 964-972.
Горпинченко .І., Гурженко Ю.М., Спиридоненко В.В. Сучасні дані про вплив хронічного запалення в патогенезі доброякісної гіперплазії передміхурової залози і раку передміхурової залози // Здоровье мужчины. – 2014. – № 4. – С. 91–94.
Coulson S, Rao A, Beck SL, Steels E, Gramotnev H, Vitetta L. A phase II randomised double blind placebo-controlled clinical trial investigating the efficacy and safety of ProstateEZE Max: a herbal medicine preparation for the management of symptoms of benign prostatic hypertrophy. Complement Ther Med. 2013 Jun;21(3):172-9.
Bains SN, Hamilton RG, Abouhassan S, Lang D, Han Y, Hsieh FH. Identification of clinically relevant cross-sensitization between Soliadgo virgaurea (goldenrod) and Hevea brasiliensis (natural rubber latex). J Investig Allergol Clin Immunol. 2010;20(4):331-9.
Back CG, Nam GY, Lee SY, Jung HY. Outbreak of Rust Caused by Coleosporium asterum on Solidago virgaurea var. gigantea in Ulleung-do. Mycobiology. 2014 Mar;42(1):79-81.
Apáti P, Houghton PJ, Kéry A. HPLC investigation of antioxidant components in Solidago herba. Acta Pharm Hung. 2004;74(4):223-31.
European Goldenrod // Herbal Medicines. – 4th edition. – 2013. – 928 p. Assessment report on Soidago virgaurea L. herba // European Medicines Agency. – 2008.
International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society / Gupta K., Hooton T.M., Naber K.G. et al. // Clin. Infect. Dis. – 2011. – V. 52, № 5. – P. 103–120.
Chevalier M, Medioni E, Prêcheur I. Inhibition of Candida albicans yeasthyphal transition and biofilm formation by Solidago virgaurea water extracts. J Med Microbiol. 2012 Jul;61(Pt 7):1016-22.
Melzig M.F. New aspects for understanding the mechanism of the aquaretic effects of birch leaves and goldenrod // Zeitschrift fur Phytotherapie. – 2000. – V. 21, № 4. – P. 193–196.
Применение золотарника обыкновенного, хвоща полевого и лапчатки гусиной (Солидагорен) / А.В. Савустьяненко// Новости медиц. и фарм. – 2015. – № 6. – С. 12–17.
Wagener H.H. Zur Pharmakologie eines Solidago-Extrakt-haltigen Venenmittels // Arzneimittelforschung. – 1966. – V. 16. – P. 859–866.
Meyer B., Schneider W., Elstner E.F. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea // Arzneimittelforschung. – 1995. –V. 45, № 2. – P. 174–176.
Plohmann B., Bader G.T., Hiller K., Franz G. Immunomodulatory and antitumoral effects of triterpenoid saponins // Pharmazie. – 1997. – V. 12. – P. 953–957.
Plohmann B., Franz G., Bader G., Hiller K. Immunmodulatorische und antitumorale Aktivität von Tri-terpensaponinen aus Solidago virgaurea L. // Drogenreport. – 1999. – V. 12. – P. 29–30.
Schmitt M. Echte Goldrute normaliesiert die Reizblase. Effective und nebenwirkungsarme Behandlung abakterieller Cystiden // TW Urologie Nephrologie. – 1996. – V. 8. – P. 133–135.
Kruedener S. von, Schneider W., Elstner E.F. A combination of Populus tremula, Solidago virgaurea and Fraxinus excelsior as an anti-inflammatory and antirheumatic drug. A short review. Arzneimittelforschung. 1995 Feb;45(2):169-71.
Chodera A, Dabrowska K, Sloderbach A, Skrzypczak L, Budzianowski J. Effect of flavonoid fractions of Solidago virgaurea L on diuresis and levels of electrolytes. Acta Pol Pharm. 1991;48(5-6):35-7.
Apáti P., Szentmihályi K., Kristó S.T. et al. Herbal remedies of Solidago–correlation of phytochemical characteristics and antioxidative properties. J Pharm Biomed Anal. 2003 Aug 8;32(4-5):1045-53.
Wu B., Takahashi T, Kashiwagi T, Tebayashi S, Kim CS. New flavonoid glycosides from the leaves of Solidago altissima. Chem Pharm Bull (Tokyo). 2007 May;55(5):815-6.
Gross SC, Goodarzi G, Watabe M, Bandyopadhyay S, Pai SK, Watabe K. Antineoplastic activity of Solidago virgaurea on prostatic tumor cells in an SCID mouse model. Nutr Cancer. 2002;43(1):76-81.
El-Tantawy W.H. Biochemical effects of Solidago virgaurea extract on experimental cardiotoxicity. J Physiol Biochem. 2014 Mar;70(1):33-42.
Marczyiński Z. Tableting technology of a dry extract from Solidago virgaurea L. with the use of silicified microcrystalline cellulose (Prosolv) and other selected auxiliary substances. Polim Med. 2009;39(4):51-60.
Berner-Strzelczyk A, Kołodziejska J, Piechota-Urbańska M, Zgoda MM. The evaluation of ketoprofen pharmaceutical availability in the presence of a dry extract from goldenrod (Solidago virgaurea L.) of synthetic polymer vehicles. Polim Med. 2009;39(4):39-44.
Starks CM, Williams RB, Goering MG, O’Neil-Johnson M, Norman VL, Hu JF, Garo E, Hough GW, Rice SM, Eldridge GR. Antibacterial clerodane diterpenes from Goldenrod (Solidago virgaurea). Phytochemistry. 2010 Jan;71(1):104-9.
Nair R, Kalariya T, Chanda S. Antibacterial activity of some plant extracts used in folk medicine. J Herb Pharmacother. 2007;7(3-4):191-201.
Pagano E, Laudato M, Griffo M, Capasso R. Phytotherapy of benign prostatic hyperplasia. A minireview. Phytother Res. 2014 Jul;28(7):949-55.
Tomar PP, Nikhil K, Singh A, Selvakumar P, Roy P, Sharma AK. Characterization of anticancer, DNase and antifungal activity of pumpkin 2S albumin. Biochem Biophys Res Commun. 2014 Jun 13;448(4):349-54.
Medical lexicon: a dictionary of medical science: containing a concise explanation of the various subjects and terms of physiology, pathology, hygiene, therapeutics, pharmacology, obstetrics, medical jurisprudence, &c., with the French and other synonyms : notices of climate, and of celebrated mineral waters : formulae for various officinal, empirical, and dietetic preparations, etc . Philadelphia: Blanchard and Lea, 1855. Text 927, 32 p.
Лікарські рослини: Енциклопедичний довідник / Відп. ред. А.М. Гродзінський. – К.: Голов. ред. УРЕ, 1990. – 544 с.
Chrubasik S, Pollak S. Pain management with herbal antirheumatic drugs. WienMed Wochenschr. 2002;152(7-8):198-203.
Krylova SG, Zueva EP, Razina TG, Turetskova VF, Amosova EN. A dried aspenbark extract in the experimental therapy of gastric peptic ulcer. Eksp Klin-Farmakol. 2000 Mar-Apr;63(2):44-7.
Amosova E.N., Zueva E.P., Razina T.G. et al. The search for new antiulcer agents from plants in Siberia and the Far East. Eksp Klin Farmakol. 1998 Nov-Dec;61(6):31-5.
Gundermann K.J., Müller J. Phytodolor-effects and efficacy of a herbal medicine. Wien Med Wochenschr. 2007;157(13-14):343-7.
Информация для медицинских и фармацевтических работников для использования в профессиональной деятельности. Простамед: Р.С. МЗ Украины UA/6931/01/01 от 16.11.2012.
Горпинченко И.И., Гурженко Ю.Н. (2012) Применение препарата Простамед в комплексном лечении больных с экскреторно-токсическим бесплодием // Здоровье мужчины, № 1 (40). – С.141–148.
Гурженко Ю.Н., Аксенов П.В. (2012) Препарат Простамед в лечении больных доброкачественной гиперплазией предстательной железы // Інформаційне повідомлення з проблеми «Сексопатологія та андрологія», Протокол № 5 від 24.05.2012.
Горпинченко И.И., Гурженко Ю.Н., Спиридоненко В.В. Применение препарата Простамед в комплексном лечении больных хроническим простатитом, осложненным экскреторно-токсическим бесплодием. Материалы научно-практической конференции «Урология, андрология, нефрология-2014» 28-30.05.2014, Харьков, С. 86–93.